| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $424,222,840 ) (Continued on the next page) |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | K23HL183763 | Leveraging the Electronic Health Record to Improve Primary Care Clinicians' Prescribing of Remote Patient Monitoring for Hypertension | 000 | 1 | NIH | 8/24/2026 | $186,706 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | F31HD123983 | Force transmission through Cell–Cell and Cell–Matrix interactions in a bilayered epithelium during Wound Healing | 002 | 1 | NIH | 8/31/2026 | $0 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | F31HD123983 | Force transmission through Cell–Cell and Cell–Matrix interactions in a bilayered epithelium during Wound Healing | 001 | 1 | NIH | 8/11/2026 | $0 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | F31HD123983 | Force transmission through Cell–Cell and Cell–Matrix interactions in a bilayered epithelium during Wound Healing | 000 | 1 | NIH | 8/11/2026 | $50,114 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01ES037626 | Nickel exposure disrupts Sp1/ZEB1-dependent transcriptional regulation | 000 | 1 | NIH | 6/23/2026 | $3,234,310 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | K08AI187792 | Genome-Wide fitness analysis of Group B Streptococcus in intestinal colonization | 000 | 1 | NIH | 8/19/2026 | $206,496 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01NS150461 | Mechanisms of assembly of endocytic machinery at the periactive zone and coupling to the presynaptic active zone | 000 | 1 | NIH | 8/11/2026 | $550,743 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | F30HL184779 | TRPM4 Channels and Cardiac Conduction Disease | 000 | 1 | NIH | 8/19/2026 | $55,114 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | F31AI203423 | Investigating the effect of variable interferon signaling on CD4+ T cells | 000 | 1 | NIH | 8/25/2026 | $50,114 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | F31HD123711 | Medication Use in Mothers with Mental Illness (MUMMI) | 000 | 1 | NIH | 8/25/2026 | $34,114 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R35GM166362 | Uncover the Molecular Mechanisms of Mutation Effects with Artificial Intelligence | 000 | 1 | NIH | 7/14/2026 | $466,125 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01AG077103 | Septhohippocamal connectome dysfunction in Down syndrome associated with Alzheimer’s disease pathophysiology | 001 | 2 | NIH | 3/16/2026 | $80,543 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01AG077103 | Septhohippocamal connectome dysfunction in Down syndrome associated with Alzheimer’s disease pathophysiology | 000 | 2 | NIH | 2/5/2026 | $724,879 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R33AG086824 | Kidney Disease Aging Research Collaborative (KDARC) Research Infrastructure to Advance the Science of Geriatric Nephrology | 000 | 3 | NIH | 6/19/2026 | $827,199 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | K01AG092933 | Exploring the impact of obesity on dementia/Alzheimer’s disease among older end-stage kidney disease patients | 000 | 1 | NIH | 7/14/2026 | $137,245 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | F31HL182260 | DIAPH1, Macrophages and Atherosclerosis | 001 | 1 | NIH | 6/16/2026 | $0 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | F31HL182260 | DIAPH1, Macrophages and Atherosclerosis | 000 | 1 | NIH | 6/16/2026 | $43,425 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R37CA304431 | Induction, Prediction and Impacts of APOBEC3 Mutagenesis in Cancer | 000 | 1 | NIH | 7/29/2026 | $701,574 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01HL183504 | Proteomics, outcomes and precision treatment of patients with chronic limb threatening ischemia (CLTI). | 000 | 1 | NIH | 8/13/2026 | $872,787 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | K01HL188929 | Digital Sleep Intervention for Families of Young Children | 000 | 1 | NIH | 9/4/2026 | $184,873 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | UG3CA309249 | The Non Invasive Post Polypoectomy Surveillance Study (NIPPSS) | 000 | 1 | NIH | 9/3/2026 | $671,426 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | H79SM091321 | The Center for Safe and Effective Trauma Treatment (CSETT) | 000 | 1 | SAMHSA | 9/2/2026 | $599,600 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01DK146063 | Identifying Neural and Computational Underpinnings of Self-Control Costs in Obesity and Loss-of-Control Eating | 000 | 1 | NIH | 9/3/2026 | $861,091 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01DK149150 | Effect of State-Wide Centralized Patient Coaching about Live Donor Kidney Transplantation | 000 | 1 | NIH | 9/2/2026 | $877,742 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01CA316857 | Microplastics, Pesticides and Prostate Cancer Risk | 000 | 1 | NIH | 9/4/2026 | $387,731 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | F30DC023485 | Neural dynamics underlying target-background separation in olfactory bulb | 000 | 1 | NIH | 9/4/2026 | $43,667 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | U01AI198070 | HOPE Heart study: A Clinical Trial of HIV to HIV Transplantation | 002 | 1 | NIH | 8/18/2026 | -$1,717,417 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | U01AI198070 | HOPE Heart study: A Clinical Trial of HIV to HIV Transplantation | 002 | 1 | NIH | 8/18/2026 | $1,717,417 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | U01AI198070 | HOPE Heart study: A Clinical Trial of HIV to HIV Transplantation | 001 | 1 | NIH | 8/5/2026 | $0 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01CA307096 | Integrated biologic technologies for selective inhibition of intracellular oncoproteins | 000 | 1 | NIH | 7/16/2026 | $595,993 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R21CA299801 | Overcoming immune evasion in chordoma by therapeutic targeting of the hypoxia-regulated adenosine pathway | 000 | 1 | NIH | 8/6/2026 | $435,827 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | DP2AI200959 | Modulation of MHC-I antigen presentation in immune surveillance and evasion by viruses and tumors | 000 | 1 | NIH | 8/5/2026 | $508,500 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R00EB035163 | Open-Source Software Tools for Rapid Radiofrequency Coil Modeling and Simulation in MRI | 000 | 3 | NIH | 7/15/2026 | $248,999 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | U01AI198070 | HOPE Heart study: A Clinical Trial of HIV to HIV Transplantation | 000 | 1 | NIH | 4/21/2026 | $1,717,417 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01AA033092 | A precision prevention approach to identifying and addressing behavioral health treatment gaps to reduce the population burden of suicide | 000 | 1 | NIH | 8/6/2026 | $2,920,164 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01MH142533 | Big data, developing brains: The neurobiological origins of fearful temperament | 000 | 1 | NIH | 8/13/2026 | $837,599 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01CA302397 | The Cellular Properties and Pathogenesis of Double-Null Prostate Cancer | 000 | 1 | NIH | 9/1/2026 | $580,131 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01HL181640 | Mechanisms of Sex-specific responses to obstructive sleep apnea Therapies (MoST) | 000 | 1 | NIH | 8/31/2026 | $795,421 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01DA063711 | NY MOVES: Evaluating the Impact of New York’s Methadone Outreach VEhicleS | 001 | 2 | NIH | 5/25/2026 | $775,500 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | K23HD120657 | Drivers and Consequences of Movement Anxiety after Stroke | 000 | 1 | NIH | 8/31/2026 | $179,495 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01AG099916 | Post-Kidney Transplant Dementia and Alzheimer's Disease Prediction Leveraging the Pre-Transplant Evaluation Data | 000 | 1 | NIH | 9/1/2026 | $1,423,551 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | K99EY037847 | Investigating the mechanism of corneal lens development | 001 | 2 | NIH | 8/25/2026 | $142,749 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R34CA313437 | Development and feasibility testing of a mobile app to deliver an evidence-based intervention targeting financial stress and smoking | 000 | 1 | NIH | 6/26/2026 | $310,185 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R21NS153418 | Characterization of ARIA by neuroimaging, proteomics, and neuropathology in a Squirrel monkey model of sporadic CAA | 000 | 1 | NIH | 9/1/2026 | $466,125 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R00EB036080 | Fast High-Resolution Microstructure Diffusion MRI Exploiting Data Redundancy | 000 | 3 | NIH | 9/1/2026 | $248,999 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R33MH131041 | Promoting Mental Health of Teachers and Caregivers using a Personalized mHealth Toolkit in Uganda | 003 | 4 | NIH | 9/3/2026 | $97,132 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01DC023790 | Cortical mechanisms of normal and disordered human speech | 000 | 1 | NIH | 6/26/2026 | $685,327 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R33MH131041 | Promoting Mental Health of Teachers and Caregivers using a Personalized mHealth Toolkit in Uganda | 002 | 4 | NIH | 8/24/2026 | $186,555 |
| | 2026 | 2026 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | UM1DA064531 | “GLP-1 Outcomes with people Using Psychoactive Substances (GLOW-UPS): a multi-stage, multi-site trial among persons involved in the criminal-legal system | 001 | 2 | NIH | 7/16/2026 | $1,374,439 |
|
